A novel strategy for people with opioid use disorder has the potential to transform lives and improve outcomes, and may ...

“It has been two weeks since the government of the DRC declared an Ebola outbreak …So far, 48 confirmed and probable cases ...

Counsellor Reshmi Singh says teen mothers face multiple challenges, including financial strain, stigma, and the risk of ...

These results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions." A majority of cancer drugs approved in the US ...

NEWS. WESH TWO HAS NEW VIDEO ON THE MURDER OF A BREVARD COUNTY FOOTBALL STAR. WE WERE THE FIRST TO TELL YOU IN MAY WHEN A FIGHT IN DOWNTOWN MELBOURNE ENDED WITH 19 YEAR OLD NATE JENNINGS DEAD. THANK ...

The trial for a New Jersey man charged with killing his brother along with his brother’s wife and two children almost seven years ago has been delayed again as the prosecution and defense argue about ...

Not even 24 hours after Donna Adelson was read her guilty verdict, a woman on the 12-person jury took to TikTok to dish about her time in the courtroom. Jurors were tasked with weighing Adelson's ...

WEEKEND FORECAST IN JUST A COUPLE MINUTES. ALL RIGHT TONY. WELL, THE STATE ATTORNEY’S OFFICE RESTED ITS CASE IN THE TRIAL AGAINST A WEST MELBOURNE MOTHER ACCUSED OF KILLING HER THREE YEAR OLD SON. NOW ...

Mark Foti (right) and Eric Soehnlein (left) represent convicted Pharaoh’s owner Peter Gerace. Attorneys for the convicted owner of Pharaoh's Gentlemen's Club, Peter Gerace, believe he should be ...

COLUMBIA, S.C. (WIS) - A former South Carolina state lawmaker has elected to represent himself in his upcoming federal trial. RJ May appeared in federal court on Thursday for a status hearing, where ...

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...

Citing a “new evidenced based philosophy,” the FDA’s Center for Biologics Evaluation and Research (CBER) is preparing to take a hard line against the common practice of administering certain ...